Jeff Allen, president and CEO of Friends of Cancer Research, shares what he hopes continuing advancements and the Cancer Moonshot will achieve in cancer care.
Jeff Allen, president and CEO of Friends of Cancer Research, shares what he hopes continuing advancements and the Cancer Moonshot will achieve in cancer care.
Allen expressed that one day he hopes that cancer treatments become more widely available for people. This includes getting them on to the marker earlier by speeding up the development process, as well as knocking down any health and geographic barriers that can create health disparities.
He also mentioned the need to address the challenges of long-term cancer treatment and letting the patients play a key role in their treatment decision making. To do this, it is important that there are resources to help them make informed decisions.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More